MAIA
MAIA clinical trials: MAIA Biotechnology, Inc.
Every trial on ClinicalTrials.gov where MAIA Biotechnology, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 2
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MAIA on the catalyst calendar · MAIA registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Sep 30, 2027Sponsor estimate | NCT05208944THIO Sequenced With Cemiplimab in Advanced NSCLCMaia Biotechnology · Carcinoma, Non-Small-Cell Lung | MAIALead | Phase 2 | Active, not recruiting | Locked | Locked | Locked |
| Jul 31, 2027Sponsor estimate | NCT06908304A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCMaia Biotechnology · Carcinoma, Non-Small -Cell Lung | MAIALead | Phase 3 | Recruiting | Locked | Locked | Locked |
| Sep 1, 2029Sponsor estimate | NCT07446257THIO and Cadonilimab in Resectable Hepatocellular CarcinomaUniversity of Texas Southwestern Medical Center · Resectable Hepatocellular Carcinoma | MAIACollaborator | Early Phase 1 | Recruiting | Locked | Locked | Locked |
- Primary completion Sep 30, 2027Sponsor estimatePhase 2NCT05208944THIO Sequenced With Cemiplimab in Advanced NSCLCMaia Biotechnology · Carcinoma, Non-Small-Cell LungActive, not recruitingMAIALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2027Sponsor estimatePhase 3NCT06908304A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCMaia Biotechnology · Carcinoma, Non-Small -Cell LungRecruitingMAIALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 1, 2029Sponsor estimateEarly Phase 1NCT07446257THIO and Cadonilimab in Resectable Hepatocellular CarcinomaUniversity of Texas Southwestern Medical Center · Resectable Hepatocellular CarcinomaRecruitingMAIACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner